NY Times (12/1/2024) & Rolling Stone (12/3/2024)
“The National Institutes of Health, the world’s leading public funder of biomedical research, has an enviable track record. Research supported by the agency has led to more than 100 Nobel Prizes and has supported more than 99 percent of the drugs approved by federal regulators from 2010 to 2019.”
“Virtually all other countries negotiate drug prices. Congress’ decision to bar Medicare from negotiating drug prices two decades ago is a major reason why Americans pay far more for the same treatments than people in other wealthy countries, even though the U.S. government subsidizes research and development on virtually all drugs that are approved for sale.”
